ViiV Healthcare Pty Ltd

Products registered by this manufacturer, by market.

Manufacturer / marketing-authorisation holder

ViiV Healthcare Pty Ltd — 42 products across 1 markets, 30 brand names. Products are grouped by country; brand names link to their brand page and ingredients to the ingredient or combination page. It is the marketing-authorisation holder recorded by the regulator, not necessarily the factory.

ViiV Healthcare Pty Ltd — 42 productos en 1 mercados, 30 nombres comerciales. Los productos se agrupan por país; los nombres comerciales enlazan a su página de marca y los principios activos a la página del principio o de la combinación. Es el titular registrado por el regulador, no necesariamente la fábrica.

ViiV Healthcare Pty Ltd —— 共 42 个产品,覆盖 1 个市场、30 个品牌名。产品按国家分组;品牌名链到品牌页,成分链到成分页/组合页。这里记录的是监管数据里的「上市许可持有人」,不一定是生产工厂。

42 products · 1 markets · 30 brand names

42 productos · 1 mercados · 30 marcas

42 个产品 · 1 个市场 · 30 个品牌名

Products by country

AU (42 records)

Source: data-api.health.gov.au

BrandActive ingredient(s)Form
3TC拉米夫定tablet
3TC拉米夫定liquid
3TC拉米夫定tablet
3TC lamivudine 10mg/mL oral liquid solution bottle拉米夫定liquid
3TC lamivudine 150mg tablet bottle拉米夫定tablet
3TC lamivudine 150mg tablet bottle拉米夫定tablet
APRETUDE cabotegravir (as sodium) 30 mg film coated tablet bottleCabotegravir Sodiumtablet
APRETUDE cabotegravir 600 mg/3 mL prolonged-release suspension for injection vialCabotegravirinjection
CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vialsCabotegravir + Rilpivirineinjection
CABENUVA cabotegravir 600 mg/3 mL plus rilpivirine 900 mg/3 mL prolonged-release suspensions for injection vialsCabotegravir + Rilpivirineinjection
CELSENTRI maraviroc 150 mg tablets blister packsMaraviroctablet
CELSENTRI maraviroc 150 mg tablets blister packsMaraviroctablet
COMBIVIR拉米夫定 + 齐多夫定tablet
COMBIVIR (lamivudine 150mg and zidovudine 300mg) tablet blister pack拉米夫定 + 齐多夫定tablet
CabenuvaCabotegravir + Rilpivirineinjection
Celsentri 150mg tabletsMaraviroctablet
Celsentri 150mg tabletsMaraviroctablet
DOVATO 50/300 dolutegravir (as sodium) 50 mg/lamivudine 300 mg tablet bottleDolutegravir Sodium · 拉米夫定tablet
Dovato多替拉韦 + 拉米夫定tablet
JULUCA dolutegravir (as sodium) 50 mg/ rilpivirine (as hydrochloride) 25 mg tablet bottle多替拉韦 · Rilpivirine Hydrochloridetablet
Juluca多替拉韦 + Rilpivirinetablet
KIVEXA abacavir 600 mg (as sulfate) and lamivudine 300 mg tablet blister packAbacavir Sulfate · 拉米夫定tablet
RETROVIR齐多夫定capsule
RETROVIR齐多夫定capsule
RETROVIR齐多夫定liquid
RETROVIR syrup zidovudine 50mg/5mL bottle齐多夫定liquid
RETROVIR zidovudine 100mg capsule blister pack齐多夫定capsule
RETROVIR zidovudine 100mg capsule blister pack齐多夫定capsule
RUKOBIA fostemsavir (as trometamol) 600 mg extended release tablet bottleFostemsavir Trometamoltablet
TIVICAY PD dolutegravir (as sodium) 5 mg dispersible tablet bottleDolutegravir Sodiumtablet
TIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottleIngredient not recorded (name-level)tablet
TIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottleDolutegravir Sodiumtablet
TIVICAY dolutegravir (as sodium) 50 mg film-coated tablet bottleDolutegravir Sodiumtablet
TRIUMEQ dolutegravir (as sodium) 50 mg/abacavir (as sulfate) 600 mg/lamivudine 300 mg tablet bottleAbacavir Sulfate · 多替拉韦 · 拉米夫定tablet
Tivicay多替拉韦tablet
TriumeqAbacavir + 多替拉韦 + 拉米夫定tablet
VOCABRIA cabotegravir (as sodium) 30 mg film-coated tablet, bottleCabotegravirtablet
VocabriaCabotegravirtablet
ZIAGENAbacavirtablet
ZIAGENAbacavirliquid
ZIAGEN abacavir (as sulfate) 20mg/mL oral solution bottleAbacavir Sulfateliquid
ZIAGEN abacavir (as sulfate) 300mg tablet blister packAbacavir Sulfatetablet
Source & licence: product rows link to the regulator record (openFDA, dm+d, CIMA, COFEPRIS, PBS/TGA, Health Canada DPD, NHSA); facts only — see the licence register.